Player FM - Internet Radio Done Right
Checked 6d ago
Đã thêm cách đây tám năm
Nội dung được cung cấp bởi Taylor & Francis Group and Francis Group. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Taylor & Francis Group and Francis Group hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
Player FM - Ứng dụng Podcast
Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
Podcast đáng để nghe
TÀI TRỢ BỞI
Y
You Can’t Make This Up


At the dawn of the social media era, Belle Gibson became a pioneering wellness influencer - telling the world how she beat cancer with an alternative diet. Her bestselling cookbook and online app provided her success, respect, and a connection to the cancer-battling influencer she admired the most. But a curious journalist with a sick wife began asking questions that even those closest to Belle began to wonder. Was the online star faking her cancer and fooling the world? Kaitlyn Dever stars in the Netflix hit series Apple Cider Vinegar . Inspired by true events, the dramatized story follows Belle’s journey from self-styled wellness thought leader to disgraced con artist. It also explores themes of hope and acceptance - and how far we’ll go to maintain it. In this episode of You Can't Make This Up, host Rebecca Lavoie interviews executive producer Samantha Strauss. SPOILER ALERT! If you haven't watched Apple Cider Vinegar yet, make sure to add it to your watch-list before listening on. Listen to more from Netflix Podcasts .…
Future Science Group
Đánh dấu tất cả (chưa) nghe ...
Manage series 1258384
Nội dung được cung cấp bởi Taylor & Francis Group and Francis Group. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Taylor & Francis Group and Francis Group hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
Podcast by Taylor & Francis Group
…
continue reading
288 tập
Đánh dấu tất cả (chưa) nghe ...
Manage series 1258384
Nội dung được cung cấp bởi Taylor & Francis Group and Francis Group. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Taylor & Francis Group and Francis Group hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
Podcast by Taylor & Francis Group
…
continue reading
288 tập
Tất cả các tập
×F
Future Science Group

1 Cell therapies for autoimmune diseases: a podcast with Lindsay Davies 13:17
13:17
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích13:17
This International Women’s Day, we’re joined by Lindsay Davies, Chief Scientific Officer at NextCell Pharma (Stockholm, Sweden), to discuss the evolving role of cell therapies in treating autoimmune diseases. In this podcast, Davies breaks down the science behind NextCell’s mesenchymal stromal cell therapy for type 1 diabetes and explores how these cells could be applied to other autoimmune conditions. She emphasizes the importance of tailoring cell therapies based on disease type, stage and patient profile to achieve the best outcomes. The conversation also highlights how growing evidence of sex-related differences will could increasingly shape decisions in the development and testing of cell therapies.…
F
Future Science Group

1 The use of GenAI in bioanalysis: an interview with Priyata Kalra 28:30
28:30
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích28:30
During the American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 2024 conference, Bioanalysis Zone caught up with industry experts across numerous disciplines to discuss their involvement with AAPS and their research. In this interview, we spoke to Priyata Kalra about her talk on the use of GenAI within biomedicine.…
F
Future Science Group

1 The need for HRMS for quantitation of ADCs vs. QQQ: an interview with Megan Cooley 21:35
21:35
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích21:35
In this episode, we sit down with Megan Cooley, Associate Director of Bioanalytical Services at ICON (KS, USA), to explore the cutting-edge world of antibody-drug conjugate (ADC) quantitation using high-resolution mass spectrometry (HRMS). Megan delves into the capabilities of Triple Quadrupole and Time-of-Flight mass spectrometry, offering her expert insights into whether HRMS is essential for ADC PK studies. We also tackle the challenges and limitations of HRMS in ADC quantitation and discuss the potential for AI to create more specific and stable ADCs. Finally, Megan highlights ICON’s extensive experience with large molecule applications and their innovative approach to supporting complex LC–MS analyses.…
F
Future Science Group

1 How can medical device regulation catch up with innovation? 12:36
12:36
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích12:36
In this interview, we discuss the potential of AI in increasing healthcare system efficiency, how medical devices are making procedures less invasive and what those working in the field of medical devices can do to help regulation catch up with innovation.
F
Future Science Group

1 The new frontier: assessing efficacy and safety of CGTs using biomarkers 24:21
24:21
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích24:21
In the sixth episode of The new frontier podcast, we're joined by Catherine Vrentas, Life Sciences Lead at Booz Allen Hamilton (VA, USA). Cathy explains how biomarkers can be used to predict the therapeutic outcome and efficacy of CGTs and the biomarkers in particular that have shown strong predictive value. We delve into the common challenges of working with biomarkers in CGTs and how biomarker kits can be adapted for CGT work.…
F
Future Science Group

Carlon Fitzpatrick AI Summit by Taylor & Francis Group
F
Future Science Group

1 Challenges and solutions in monitoring assay performance for vaccine development 18:26
18:26
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích18:26
Challenges and solutions in monitoring assay performance for vaccine development: an interview with Atul Chaudhari
F
Future Science Group

1 ADA detection and characterization for immunogenicity testing: insights from ICON's Lindsay Denhoff 11:13
11:13
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích11:13
We caught up with Principal Scientist Lindsay Denhoff (ICON; Dublin, Ireland) to discuss immunogenicity considerations for therapeutic proteins and the current analytical methodologies for detecting and characterizing anti-drug antibodies (ADAs). Lindsay shares some industry best practices for achieving high-quality ADA assays, as well as some of the advantages and limitations of singlicate ADA analysis compared with alternative techniques. We finish the interview with a look to the future where Lindsay discusses the emerging trends she's spotted in the field of immunogenicity and offers her predictions for how they may shape the future of therapeutic protein development.…
F
Future Science Group

In this Tech Blast episode supported by Sartorius (Göttingen, Germany), we speak with David Apiyo – Manager of Applications Development at Sartorius (MN, USA) – about epitope binning, why it's performed and the best ways to conduct it. Plus, learn more about Sartorius' biolayer interferometry platforms and their application in epitope binning.…
F
Future Science Group

1 Using the Gyrolab® platform for oligo quantification: an interview with John Chappell 6:35
6:35
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích6:35
In this interview, we spoke to John Chappell, Senior Global Scientific Support Manager at Gyros Protein Technologies (Uppsala, Sweden) about his experience working with the Gyrolab platform for oligonucleotide assays. John discusses the advantages of using Gyrolab for oligo quantification in biological fluids and shares his thoughts on the next steps for these assays.…
F
Future Science Group

1 The new frontier: qPCR vs ddPCR for cell and gene therapies 15:41
15:41
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích15:41
In the fifth episode of The New Frontier podcast, we're joined by Paul Byrne, Senior Director of Genomics from ProtaGene (MA, USA). Paul describes his experience working with qPCR vs digital and digital droplet PCR assays and advises on their pros and cons, as well as when it's best to use each. We discuss how these assays can be optimized for cell and gene therapy targets and get a peek into the tips and tricks he's picked up over his 30 years of experience.…
F
Future Science Group

1 The new frontier: using LC–MS/MS for quantitative assays to support gene therapies 13:33
13:33
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích13:33
In this episode of The New Frontier podcast, we're joined by Daniel Schulz-Jander, Senior Director of Mass spectrometry Bioanalysis at QPS Netherlands (Groningen). Daniel explains how he uses immune-precipitation and immunoaffinity LC–MS techniques for his work relating to macromolecular pharmaceuticals like gene therapies, as well as their benefits and challenges. Daniel also covers bottom-up, middle-down and top-down approaches and their suitability for his work in clinical support versus research and discovery.…
F
Future Science Group

1 Breaking down barriers for women in tech: an interview with Tina Marshall 16:15
16:15
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích16:15
Breaking down barriers for women in tech: an interview with Tina Marshall by Taylor & Francis Group
F
Future Science Group

1 Uncovering the link between cancer disparities and climate change 14:35
14:35
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích14:35
What disparities exist in cancer screening and how does this impact patient outcomes? Listen to our latest podcast episode with Kilan Ashad-Bishop (American Cancer Society) to find out about the intersection between science, health, and society.
F
Future Science Group

1 AI-driven early disease detection: an interview with Jim Kean 28:19
28:19
Nghe Sau
Nghe Sau
Danh sách
Thích
Đã thích28:19
AI-driven early disease detection: an interview with Jim Kean by Taylor & Francis Group
Chào mừng bạn đến với Player FM!
Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.